Pivotal Research analyst Timothy Ramey made no changes to his estimates or $62 price target on Herbalife Nutrition shares following news that CEO Rich Goudis was forced out of his position due to comments he made that the company said “were inconsistent with Herbalife Nutrition’s standards and do not reflect the company’s culture.” Ramey said Herbalife has “a strong management team with an excellent leadership group” and that he is “certain that the company remains in exceptionally strong hands.” He keeps a Buy rating on Herbalife shares, which are down about 2% to $57 in pre-market trading.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.